Functional studies revealed that FAM222A-AS1 promoted growth and progression of CRC cells in vitro and in vivo by sponging miR-let-7f to promote the expression of MYH9, indicating a tumor-accelerant role in CRC. Here, FAM222A is linked to neoplasm.